Category: Static

Hartford HealthCare receives credit rating upgrade

Harford (Conn.) HealthCare has seen its current debt assigned an “AA” rating, up from “A,” S&P Global said Aug. 23.

500 patients potentially exposed to tuberculosis at Indiana hospital

Clark Memorial Health in Jeffersonville, Ind., is notifying patients of a potential exposure to tuberculosis after one of its employees recently tested positive for the disease, the News and Tribune reported Aug. 22.

Allina calls off billing practice that drew national attention

Minneapolis-based Allina Health announced Aug. 23 that it is ending a billing and collection policy that drew national attention and an investigation by the the Minnesota attorney general.

FDA flags Amazon, Walmart for selling unapproved drug

The FDA warned Amazon, Walmart and two other companies for selling products for molluscum contagiosum — a viral skin infection that does not have any approved over-the-counter treatments. 

Texas Heart Institute gets $32M from patient, $1.14M for drug development

Houston-based Texas Heart Institute received a grant to develop a first-in-class drug for cardiovascular disease and received $32 million from a patient.

Chief strategy officer exits TMC Health

Kristopher Kitz has left his role as chief strategy officer of TMC Health, a four-hospital system in Tucson, Ariz.  

Boston Medical Center, physicians strike deal with 20% raise

Members of the Committee of Interns and Residents have reached a tentative agreement with Boston Medical Center.

Novant Health affiliates name chief nursing officer

Tammy Moore, RN, BSN, has been named chief  nursing officer of Davis and Lake Norman Regional Medical Centers in Mooresville, N.C. 

95% of patients say telehealth is easiest way to get diagnoses

Telemedicine received the highest ratings when 1,000 U.S. patients were asked about the easiest way to obtain a diagnosis.

AHA urges Congress to address drug shortage, preserve 340B access

The American Hospital Association stated its opposition to a drafted July 28 proposal from the U.S. House Energy and Commerce Committee that could lead to limit access to the 340B Drug Pricing Program in an Aug. 22 letter.